Frontlight ResearchEarly access
Trial site
Imperial College Healthcare NHS Foundation Trust, Hammersmith Hospital
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Pancreatic cancer2 trials
- Multiple myeloma1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Recruiting3 trials
- Lead sponsor
- Revolution Medicines, Inc.2 trials
- C4 Therapeutics, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Pancreatic cancer2 recruiting
- Multiple myeloma1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026